跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
BISACODYL SUPPOSITORY
Authorized
STANDARD
BISACODYL SUPPOSITORY
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
28ad028b777b6cf1
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
28ad028b777b6cf1
Drug Approval Canada Name
BISACODYL SUPPOSITORY
Product Name
BISACODYL SUPPOSITORY
Status
Marketed
Status Date
2020-01-27
Original Market Date
2020-01-27
Din
02489090
Drug Class
Human
Dosage Form
Suppository
Route Of Administration
Rectal
Schedule
OTC
Ahfs
56:12.00
Atc Original
A06AB02 BISACODYL
Atc Name
a 06 ab 02
Aig Number
0101506002
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
BISACODYL
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
28ad028b777b6cf1
Type
Standard
Back to Health Canada Approvals
BISACODYL SUPPOSITORY - Health Canada Drug Approval Details